Science Explorer Back to mapMap
Discussion

Vyne Therapeutics (United States)

Research works
33
▲ 227% vs 2018-21
Citations
433
13.2 per fractional work
Top-10% rate
19.2%
all institutions 10.0%
Open access
49%
world 40%
International
38%
world 18%

Not ranked overall: Vyne Therapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Vyne Therapeutics (United States) work in?

In 2022-now, 58% of research at Vyne Therapeutics (United States) is in Health Sciences, 37% in Life Sciences. Its largest fields are Medicine (56%), Biochemistry, Genetics and Molecular Biology (25%), Immunology and Microbiology (6%). It does 1.9× the world's share of Health Sciences.

Health Sciences: 12 fractional works · 58.2% of its workMedicine: 12 fractional works · 56.4% of its workPulmonary and Respiratory Medicine: 5 fractional works · 22.9% of its workOncology: 3 fractional works · 13.1% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 5.6% of its workEpidemiology: 1 fractional works · 3.7% of its workGenetics: 1 fractional works · 3.4% of its workNeurology: 0 fractional works · 1.8% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 1.4% of its workPsychiatry and Mental health: 0 fractional works · 0.9% of its workPhysiology: 0 fractional works · 0.9% of its workRheumatology: 0 fractional works · 0.8% of its workOtorhinolaryngology: 0 fractional works · 0.4% of its workInfectious Diseases: 0 fractional works · 0.3% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.3% of its workPathology and Forensic Medicine: 0 fractional works · 0.3% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.3% of its workReproductive Medicine: 0 fractional works · 0.3% of its workHealth Professions: 0 fractional works · 1.3% of its workSpeech and Hearing: 0 fractional works · 1.3% of its workNursing: 0 fractional works · 0.5% of its workNutrition and Dietetics: 0 fractional works · 0.5% of its workLife Sciences: 8 fractional works · 37.0% of its workBiochemistry, Genetics and Molecular Biology: 5 fractional works · 25.1% of its workMolecular Biology: 4 fractional works · 20.2% of its workGenetics: 1 fractional works · 3.1% of its workCancer Research: 0 fractional works · 1.6% of its workSmaller subfields together: 0 fractional works · 0.3% of its workImmunology and Microbiology: 1 fractional works · 6.4% of its workImmunology: 1 fractional works · 6.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 1 fractional works · 4.2% of its workCellular and Molecular Neuroscience: 0 fractional works · 1.6% of its workEndocrine and Autonomic Systems: 0 fractional works · 1.6% of its workCognitive Neuroscience: 0 fractional works · 1.0% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 1.3% of its workPharmaceutical Science: 0 fractional works · 0.8% of its workPharmacology: 0 fractional works · 0.5% of its workPhysical Sciences: 1 fractional works · 3.1% of its workEngineering: 0 fractional works · 2.0% of its workBiomedical Engineering: 0 fractional works · 1.6% of its workElectrical and Electronic Engineering: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.0% of its workChemistry: 0 fractional works · 0.8% of its workOrganic Chemistry: 0 fractional works · 0.8% of its workComputer Science: 0 fractional works · 0.3% of its workComputational Theory and Mathematics: 0 fractional works · 0.3% of its workSocial Sciences: 0 fractional works · 1.7% of its workArts and Humanities: 0 fractional works · 1.6% of its workVisual Arts and Performing Arts: 0 fractional works · 1.6% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.1% of its workALL ITS WORKVyne Therapeutics(United States)21fractional works, 2022-now
Life Sciences37%Physical Sciences3%Health Sciences58%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 12 fields, with their numbers
    1. Medicine1256.4%
    2. Health Professions01.3%
    3. Nursing00.5%
    1. Biochemistry, Genetics and Molecular Biology525.1%
    2. Immunology and Microbiology16.4%
    3. Neuroscience14.2%
    4. Pharmacology, Toxicology and Pharmaceutics01.3%
    1. Engineering02.0%
    2. Chemistry00.8%
    3. Computer Science00.3%
    1. Arts and Humanities01.6%
    2. Economics, Econometrics and Finance00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 4.71× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 6.30× its world share, 1 worksImmunology and Micro…Neuroscience: 2.58× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.74× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.50× its world share, 0 worksChemistryComputer Science: 0.04× its world share, 0 worksComputer ScienceEngineering: 0.13× its world share, 0 worksEngineeringHealth Professions: 0.50× its world share, 0 worksHealth ProfessionsMedicine: 2.93× its world share, 12 worksMedicineNursing: 1.08× its world share, 0 worksNursingArts and Humanities: 0.55× its world share, 0 worksArts and HumanitiesEconomics, Econometrics and Finance: 0.05× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.3×. Every wedge is a field page.

All 12 fields, with their numbers
  1. Immunology and Microbiology6.30×1 works
  2. Biochemistry, Genetics and Molecular Biology4.71×5 works
  3. Pharmacology, Toxicology and Pharmaceutics3.74×0 works
  4. Medicine2.93×12 works
  5. Neuroscience2.58×1 works
  6. Nursing1.08×0 works
  7. Arts and Humanities0.55×0 works
  8. Chemistry0.50×0 works
  9. Health Professions0.50×0 works
  10. Engineering0.13×0 works
  11. Economics, Econometrics and Finance0.05×0 works
  12. Computer Science0.04×0 works

What are the most cited papers from Vyne Therapeutics (United States)?

The most cited paper from Vyne Therapeutics (United States) is "In vivo editing of lung stem cells for durable gene correction in mice" (Yehui Sun et al., 2024), with 182 citations. Next come "Serlopitant for the treatment of chronic pruritus: Results of a randomized, multicenter, placebo-controlled phase 2 clinical trial" (120) and "Serlopitant reduced pruritus in patients with prurigo nodularis in a phase 2, randomized, placebo-controlled trial" (115).

Most cited papers
#PaperReleasedCitations
1 In vivo editing of lung stem cells for durable gene correction in mice Yehui Sun et al. · Science Open access 13 Jun 2024 182
2 Serlopitant for the treatment of chronic pruritus: Results of a randomized, multicenter, placebo-controlled phase 2 clinical trial Gil Yosipovitch, Sonja Ständer, Matthew B. Kerby et al. · Journal of the American Academy of Dermatology Open access 17 Feb 2018 120
3 Serlopitant reduced pruritus in patients with prurigo nodularis in a phase 2, randomized, placebo-controlled trial Sonja Ständer, Paul Kwon, Joe Hirman et al. · Journal of the American Academy of Dermatology Open access 17 Mar 2019 115
4 Diagnostic and treatment algorithm for chronic nodular prurigo Hartmut F. Ständer, Sarina B. Elmariah, Claudia Zeidler et al. · Journal of the American Academy of Dermatology 13 Jul 2019 100
5 Bronchial Rheoplasty for Treatment of Chronic Bronchitis. Twelve-Month Results from a Multicenter Clinical Trial Arschang Valipour, Sebastián Fernández-Bussy, Alvin Ing et al. · American Journal of Respiratory and Critical Care Medicine Open access 14 May 2020 78
All 65 most cited papers, with filters and sorting

Which keywords describe research at Vyne Therapeutics (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Immunotherapy, CFTR, Cystic Fibrosis, Lymphoma, CAR T Cells, Chimeric Antigen Receptor, Glycosylation and Monoclonal Antibodies.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 15 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 15 words, with their numbers
  1. Immunotherapy2▲ 15×4 topics
  2. CFTR2▲ 264×1 topic
  3. Cystic Fibrosis2▲ 110×1 topic
  4. Lymphoma2▲ 46×2 topics
  5. CAR T Cells2▲ 98×1 topic
  6. Chimeric Antigen Receptor2▲ 98×1 topic
  7. Glycosylation1▲ 58×2 topics
  8. Monoclonal Antibodies1▲ 67×2 topics
  9. Inhaler Devices1▲ 199×1 topic
  10. Nanoparticles1▲ 4.2×2 topics
  11. Pulmonary Drug Delivery1▲ 199×1 topic
  12. Cancer1▲ 3.7×7 topics
  13. Cancer Therapy1▲ 8.4×3 topics
  14. Fc Receptors1▲ 87×1 topic
  15. Therapeutic Antibodies1▲ 68×1 topic

Which research topics does Vyne Therapeutics (United States) publish most on?

By volume in 2022-now: Cystic Fibrosis Research Advances, CAR-T cell therapy research, Inhalation and Respiratory Drug Delivery and Monoclonal and Polyclonal Antibodies Research.

  1. 1 Cystic Fibrosis Research Advances Pulmonary and Respiratory Medicine 2 works
  2. 2 CAR-T cell therapy research Oncology 2 works
  3. 3 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 1 works
  4. 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  5. 5 Neonatal Respiratory Health Research Pulmonary and Respiratory Medicine 1 works
  6. 6 Protein Degradation and Inhibitors Molecular Biology 1 works
  7. 7 Biochemical and Structural Characterization Molecular Biology 1 works
  8. 8 Ubiquitin and proteasome pathways Molecular Biology 1 works
  9. 9 Respiratory viral infections research Epidemiology 1 works
  10. 10 Cancer Immunotherapy and Biomarkers Oncology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available49.2%not open50.8%

World: 40% of research is openly available.

with international co-authors38.0%domestic only62.0%

World: 18% is written across borders.

How has Vyne Therapeutics (United States)'s research output changed?

Output in 2022-2025 was 227% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Vyne Therapeutics (United States) as a percentage of every work published that year, 0.000077% in 2024.

still counting0.00010%0.00020%Vyne Therapeutics (United States)0.00019% in 20251990200020102020

Fractional works of Vyne Therapeutics (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Menlo Park

All research institutions in Menlo Park

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Vyne Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.